We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+57.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$253M
AUM Growth
+$105M
Cap. Flow
+$69.1M
Cap. Flow %
27.37%
Top 10 Hldgs %
50.9%
Holding
95
New
29
Increased
11
Reduced
6
Closed
23

Top Buys

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$8.24M
2
BHVN icon
Biohaven
BHVN
+$6.93M
3
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.72M
4
LRMR icon
Larimar Therapeutics
LRMR
+$5.42M
5
HELP
Cybin Inc
HELP
+$5.3M

Top Sells

Rank Stock Value
1
BOXX icon
Alpha Architect 1-3 Month Box ETF
BOXX
+$9.75M
2
ATXS
Astria Therapeutics
ATXS
+$7.32M
3
IMVT icon
Immunovant
IMVT
+$3.37M
4
ORIC icon
Oric Pharmaceuticals
ORIC
+$3.22M
5
CBAY
Cymabay Therapeutics
CBAY
+$2.62M

Sector Composition

Rank Sector Weight
1 Healthcare 85.9%
2 Consumer Discretionary 1.37%
3 Industrials 0.06%
4 Communication Services 0%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WLDSW icon
51
Wearable Devices Ltd Warrant
WLDSW
$132K
$109K 0.04%
1,961
– –
AZTR icon
52
Azitra
AZTR
$2.19M
$101K 0.04%
+2,468
New +$358K
MBTCR
53
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
$82K 0.03%
500,000
– –
QNRX
54
Quoin Pharmaceuticals
QNRX
$9.62M
$62.9K 0.02%
+1,893
New +$187K
MOBXW icon
55
Mobix Labs Warrants
MOBXW
$752K
$31.5K 0.01%
150,000
– –
VSEEW
56
DELISTED
VSEE HEALTH INC WTS 29
VSEEW
$19.2K 0.01%
150,000
– –
ONFOW icon
57
Onfolio Holdings Warrant
ONFOW
$64.5K
$8.12K ﹤0.01%
200,000
– –
NLSPW
58
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$6.88K ﹤0.01%
200,000
– –
CDTTW
59
CDT Equity Inc Warrant
CDTTW
$1.87M
$6K ﹤0.01%
100,000
– –
CINGW icon
60
Cingulate Inc Warrants
CINGW
$33.2K
$5.7K ﹤0.01%
270,000
– –
BTMWW
61
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$4.75K ﹤0.01%
50,000
– –
NXLIW
62
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$4.39K ﹤0.01%
105,000
– –
CYCUW
63
Cycurion Inc Warrant
CYCUW
$311K
$4.28K ﹤0.01%
100,000
– –
NEXRW
64
Nexera Technologies Ltd Warrant
NEXRW
$48.9K
$4.01K ﹤0.01%
68,681
– –
SRZNW icon
65
Surrozen Inc Warrant
SRZNW
$8.86K
$3.4K ﹤0.01%
82,233
– –
BNCWW
66
CEA Industries Inc Warrant
BNCWW
$3.25K ﹤0.01%
250,000
– –
OSAAW
67
DELISTED
ProSomnus, Inc. Warrant
OSAAW
$3K ﹤0.01%
150,000
– –
MITAW
68
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$1.87K ﹤0.01%
28,333
– –
SLNAW
69
DELISTED
Selina Hospitality PLC Warrant
SLNAW
$710 ﹤0.01%
101,439
– –
TCBPW
70
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$376 ﹤0.01%
18,823
– –
BRSHW
71
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$110 ﹤0.01%
14,423
– –
ACXP icon
72
PUT
Acurx Pharmaceuticals
ACXP
$6.62M
– –
-8,515
Closed -$652K
AMLX icon
73
Amylyx Pharmaceuticals
AMLX
$2.54B
– –
-119,526
Closed -$1.76M
ARVN icon
74
Arvinas
ARVN
$572M
– –
-31,210
Closed -$1.28M
BOXX icon
75
Alpha Architect 1-3 Month Box ETF
BOXX
$13.2B
– –
-92,700
Closed -$9.75M
1 2
3
4

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Altium Capital Management held 95 positions worth $253M, up 72% from $147M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Altium Capital Management deployed $69.1M of net new capital in Q1 2024, opening 29 new positions and adding to 11 existing holdings. Its largest new stake was Avadel Pharmaceuticals: 553,057 shares worth $9.34M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 89% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Astria Therapeutics, an estimated $7.32M trimmed.

  • Altium Capital Management's largest Q1 2024 buy was Avadel Pharmaceuticals: 553,057 shares worth $9.34M.
  • Altium Capital Management added most to Vera Therapeutics in Q1 2024, an estimated $3.39M increase.
  • Altium Capital Management's biggest Q1 2024 reduction was Astria Therapeutics, cutting an estimated $7.32M.
  • Altium Capital Management fully exited Alpha Architect 1-3 Month Box ETF in Q1 2024, selling an estimated $9.75M.
  • Altium Capital Management's ten largest holdings make up 51% of its $253M portfolio in Q1 2024.
  • Altium Capital Management opened 29 new positions and closed 23 in Q1 2024.
  • Altium Capital Management's portfolio value rose 72% quarter-over-quarter to $253M.

Based on Altium Capital Management's 13F filing for Q1 2024, filed 15 May 2024.